Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Other Operating Expenses (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Other Operating Expenses for 10 consecutive years, with $283895.0 as the latest value for Q4 2022.

  • Quarterly Other Operating Expenses fell 7.71% to $283895.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2022, up 5.1% year-over-year, with the annual reading at $1.3 million for FY2025, 7.54% up from the prior year.
  • Other Operating Expenses hit $283895.0 in Q4 2022 for Kraig Biocraft Laboratories, up from $255990.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $307617.0 in Q4 2021 to a low of $130526.0 in Q1 2018.
  • Historically, Other Operating Expenses has averaged $233925.8 across 4 years, with a median of $261576.0 in 2018.
  • Biggest five-year swings in Other Operating Expenses: crashed 40.79% in 2018 and later skyrocketed 105.68% in 2019.
  • Year by year, Other Operating Expenses stood at $261576.0 in 2018, then decreased by 29.73% to $183807.0 in 2019, then skyrocketed by 67.36% to $307617.0 in 2021, then dropped by 7.71% to $283895.0 in 2022.
  • Business Quant data shows Other Operating Expenses for KBLB at $283895.0 in Q4 2022, $255990.0 in Q3 2022, and $274379.0 in Q2 2022.